AlphaCrest Capital Management’s Inogen INGN Stock Holding History

AlphaCrest Capital Management’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,832	Closed	-$430K	–	1192
2020 Q3	$430K	Buy	+14,832	New	+$466K	0.05%	668
2020 Q1	–	Sell	-5,059	Closed	-$346K	–	1143
2019 Q4	$346K	Sell	5,059 -14,641	-74%	-$918K	0.03%	977
2019 Q3	$944K	Buy	+19,700	New	+$1.03M	0.06%	599

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

AlphaCrest Capital Management's INGN Position: Q4 2020 in Review

AlphaCrest Capital Management sold out of Inogen (INGN) in Q4 2020, closing a stake of 14,832 shares — an estimated $430K sold.

AlphaCrest Capital Management first reported a position in INGN in Q3 2019 and held it in 3 quarters. The position peaked at $944K in Q3 2019. 161 funds tracked by Wall St. Rank hold INGN as of Q4 2020.

AlphaCrest Capital Management reported no remaining Inogen position as of Q4 2020 after selling out during the quarter.
AlphaCrest Capital Management sold 14,832 Inogen shares in Q4 2020, an estimated $430K.
AlphaCrest Capital Management first reported a position in Inogen in Q3 2019 and held it in 3 quarters.
AlphaCrest Capital Management's Inogen position peaked at $944K in Q3 2019.
161 funds tracked by Wall St. Rank held Inogen as of Q4 2020.

Based on AlphaCrest Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.